With fresh $155M round, Gilead's former top scientist moves forward with cancer-fighting startup
August 24, 2020 at 09:00 AM EDT
Kronos Bio plans to take its lead cancer drug into a pivotal trial next year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|